| protein | Q8054 |
| P705 | Ensembl protein ID | ENSP00000227665 |
| ENSP00000399701 | ||
| ENSP00000445002 | ||
| ENSP00000501141 | ||
| P486 | MeSH descriptor ID | D000072040 |
| P672 | MeSH tree code | D10.532.091.200.575 |
| D12.776.070.400.200.575 | ||
| D12.776.521.120.200.575 | ||
| P637 | RefSeq protein ID | NP_001160070 |
| NP_001358833 | ||
| NP_443200 | ||
| P2892 | UMLS CUI | C4255107 |
| P352 | UniProt protein ID | Q6Q788 |
| P682 | biological process | acylglycerol homeostasis | Q21097374 |
| cholesterol biosynthetic process | Q14599306 | ||
| positive regulation of lipid biosynthetic process | Q14761956 | ||
| triglyceride metabolic process | Q14819245 | ||
| regulation of intestinal cholesterol absorption | Q14851915 | ||
| positive regulation of cholesterol esterification | Q14859613 | ||
| positive regulation of fatty acid biosynthetic process | Q14859629 | ||
| triglyceride catabolic process | Q14864750 | ||
| very-low-density lipoprotein particle remodeling | Q14864752 | ||
| lipoprotein metabolic process | Q14864753 | ||
| triglyceride homeostasis | Q14864754 | ||
| neuron projection regeneration | Q14864877 | ||
| positive regulation of receptor-mediated endocytosis | Q14865472 | ||
| cholesterol homeostasis | Q14872722 | ||
| lipid transport | Q14872727 | ||
| post-translational protein modification | Q898362 | ||
| reverse cholesterol transport | Q7318217 | ||
| phosphatidylcholine metabolic process | Q14878189 | ||
| cholesterol efflux | Q14890389 | ||
| phospholipid efflux | Q14890392 | ||
| high-density lipoprotein particle assembly | Q14890399 | ||
| regulation of cholesterol transport | Q14904545 | ||
| tissue regeneration | Q14906266 | ||
| regulation of lipid metabolic process | Q14906369 | ||
| positive regulation of lipoprotein lipase activity | Q14910995 | ||
| positive regulation of triglyceride catabolic process | Q14916268 | ||
| positive regulation of very-low-density lipoprotein particle remodeling | Q14916269 | ||
| triglyceride-rich lipoprotein particle remodeling | Q14916270 | ||
| positive regulation of lipid catabolic process | Q14916406 | ||
| P681 | cell component | chylomicron | Q423126 |
| endoplasmic reticulum lumen | Q14633848 | ||
| extracellular region | Q14645596 | ||
| very-low-density lipoprotein particle | Q14864742 | ||
| low-density lipoprotein particle | Q14872701 | ||
| blood microparticle | Q21095089 | ||
| extracellular space | Q1385443 | ||
| high-density lipoprotein particle | Q14878180 | ||
| P702 | encoded by | APOA5 | Q18049241 |
| P703 | found in taxon | Homo sapiens | Q15978631 |
| P680 | molecular function | lipase activator activity | Q21173177 |
| cholesterol transfer activity | Q29573259 | ||
| lipoprotein particle receptor binding | Q13667398 | ||
| lipid binding | Q14358833 | ||
| enzyme binding | Q14599289 | ||
| heparin binding | Q14819453 | ||
| cholesterol binding | Q14859820 | ||
| phospholipid binding | Q14859884 | ||
| enzyme activator activity | Q14878167 | ||
| lipase binding | Q21095126 | ||
| phosphatidylcholine binding | Q14878186 | ||
| low-density lipoprotein particle receptor binding | Q14890332 | ||
| phosphatidylcholine-sterol O-acyltransferase activator activity | Q14890337 | ||
| lipoprotein lipase activator activity | Q14910979 | ||
| P361 | part of | Apolipoprotein A/E | Q24719973 |
| Q24305221 | APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study |
| Q24291759 | An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing |
| Q24298481 | Apolipoprotein A-V interaction with members of the low density lipoprotein receptor gene family |
| Q24301565 | Apolipoprotein A-V-heparin interactions: implications for plasma lipoprotein metabolism |
| Q24291737 | Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration |
| Q24314838 | Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding |
| Q24313182 | Efficient lowering of triglyceride levels in mice by human apoAV protein variants associated with hypertriglyceridemia |
| Q24294823 | Identification of lipid binding and lipoprotein lipase activation domains of human apoAV |
| Q24322206 | Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study |
| Q24294997 | Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5 |
| Q24315970 | Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides |
| Q24305368 | Structure and interfacial properties of human apolipoprotein A-V |
| Q24311849 | The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins |
| Q50373814 | p-APOA5 [endoplasmic reticulum lumen] | subclass of | P279 |
| Q18049241 | APOA5 | encodes | P688 |
Search more.